Pinealon

Pinealon (EDR peptide, Glu-Asp-Arg) is a synthetic tripeptide belonging to a class of compounds known as peptide bioregulators, short-chain peptides developed through research spanning over four decades at the Saint Petersburg Institute of Bioregulation and Gerontology in Russia. ^(1,2,3) Professor Vladimir Khavinson, the scientist who led this work, isolated Pinealon from Cortexin, a neuroprotective polypeptide complex sourced from bovine and porcine brain cortex tissue. ^(1,2) Cortexin itself is an approved pharmaceutical in Russia with documented clinical use for neurological conditions, and Pinealon represents its smallest biologically active peptide fraction. ^(2,3)

Pinealon’s amino acid sequence is remarkably simple: just three amino acids (glutamic acid, aspartic acid, arginine) with a molecular weight of approximately 390-418 Da. ^(1,2) This simplicity is deceptive. The sequence contains two acidic residues and one basic residue, creating a mixed-charge distribution that enables the peptide to cross cellular and nuclear membranes and interact directly with DNA. This property distinguishes Pinealon from most larger peptides that rely on cell-surface receptor binding. ^(1,2,4) This ability to penetrate to the nuclear level and influence gene expression is the defining characteristic of the Khavinson bioregulator peptide class.

Each bioregulator in the Khavinson family targets a specific organ or tissue system. Pinealon’s composition gives it affinity for neurons and central nervous system tissue. ^(2,3) Its name reflects historical associations with the pineal gland, though published research demonstrates broader neuroprotective activity across cortical neurons, hippocampal cells, and spinal cord tissue. ^(1,2,3)

Pinealon is not FDA-approved for any therapeutic indication. It is not classified as a controlled substance. It is not explicitly listed on the WADA Prohibited List, though the S0 (Non-Approved Substances) catch-all provision may apply. ⁽⁶⁾ Pinealon was not included in the FDA Category 2 bulk drug substance classification in September 2023. ⁽⁷⁾ Healius supplies Pinealon as a lyophilized (also referred to as lyophilized) powder in 20mg vials, intended strictly for laboratory and research applications.

Pinealon’s mechanism of action is fundamentally different from most peptides studied in the research peptide space. Rather than binding to cell surface receptors or activating traditional signaling (also spelled signaling) cascades, Pinealon is hypothesized (also spelled hypothesized) to penetrate cellular and nuclear membranes due to its small size and charge profile, thereby enabling direct interaction with DNA sequences and chromatin-associated proteins. ^(1,2,4)

Molecular modeling (also spelled modeling) studies have identified specific DNA-binding sites where Pinealon can interact with genetic material. ⁽⁴⁾ This interaction is thought to influence transcriptional accessibility, effectively modulating gene expression at the chromatin level. Research by Fedoreyeva et al. demonstrated that short fluorescence-labeled peptides, including EDR-class tripeptides, penetrate the nucleus of HeLa cells and exhibit specific in vitro interactions with deoxyribooligonucleotides and DNA. ⁽⁴⁾

The downstream effects of this gene expression modulation include upregulation of tryptophan hydroxylase 1 (TPH1), the rate-limiting enzyme in serotonin synthesis, stimulating serotonin expression in brain cortex cells. ^(2,3) Pinealon also modulates antioxidant defense systems: upregulating glutathione peroxidase 1 (GPX1), superoxide dismutase 2 (SOD-2), and the MAPK-ERK signaling pathway, while downregulating pro-apoptotic factors including caspase-3 and p53. ^(1,2) Additionally, Pinealon influences PPARalpha and PPARgamma transcription factors, which play roles in inflammation and metabolic regulation in neural tissue. ⁽¹⁾

The practical significance of this mechanism is that Pinealon does not simply provide a temporary pharmacological effect that fades when the peptide is metabolized (also spelled metabolized). By influencing gene expression patterns, the peptide may produce effects that persist beyond its direct presence in the system, a property consistent with the bioregulator class’s aim of restoring endogenous physiological function rather than replacing it.

Pinealon research spans neuroprotection, cognitive function, sleep regulation, and anti-aging (also spelled anti-aging) neurobiology, with published data from both in vitro and animal studies, as well as limited human studies. ^(1,2,3,5)

Neuroprotection is the most extensively documented benefit. In vitro studies demonstrated that Pinealon completely prevented cell death when brain cells were exposed to hydrogen peroxide, and it protected NMDA receptors from high homocysteine-induced toxicity at concentrations lower than those of carnosine. ^(2,3) In Alzheimer’s disease models, the EDR peptide reversed damage to mushroom spines (dendritic protrusions critical for memory) in hippocampal cultures treated with amyloid-beta 42. ^(1,2) In a Huntington’s disease mouse model, Pinealon produced neuroprotective effects. ⁽³⁾ Pinealon is also patented for its ability to promote neuron regeneration and improve spinal cord injuries in rodent models. ⁽²⁾

Sleep and circadian rhythm research draws on Pinealon’s support for pineal gland function and melatonin-related pathways. Animal studies demonstrated that Pinealon treatment normalized (also spelled normalized) sleep, eating, and waking behaviors (also spelled behaviors) in stress models. ^(2,5) A study on professional truck drivers with circadian disruption found that the introduction of regulating peptides restored adaptive potential, improved physiological indices, intensified stress resistance, and reduced occupational risk of behavioral and neurological disorders. ⁽⁵⁾ Importantly, Pinealon supports endogenous pineal function rather than directly supplying melatonin, which distinguishes it from melatonin supplementation that can suppress the body’s own hormone synthesis over time.

Cognitive enhancement data includes a human trial: Kryzhanovskaya et al. ⁽²⁰¹⁴⁾ studied 60 healthy adults aged 45-65 and reported improvements in memory and cognitive performance. ⁽⁵⁾ Animal studies showed that Pinealon protected rat offspring from prenatal hyperhomocysteinemia (also spelled hyperhomocysteinemia) and correspondingly improved postnatal cognitive function. ⁽³⁾ Pinealon also maintained learning retention in rats with experimentally induced diabetes. ⁽³⁾

The comparison between Pinealon and Epithalon is the most searched peptide bioregulator comparison, and understanding the distinction is essential for researchers working with the Khavinson peptide family.

Both are short synthetic peptides developed by Vladimir Khavinson’s research group. Both are classified as peptide bioregulators that interact with gene expression. However, they target different organ systems through different mechanisms and produce different downstream effects.

Epithalon (Ala-Glu-Asp-Gly, AEDG tetrapeptide) targets the pineal gland specifically, activating telomerase and stimulating melatonin production through direct pineal cell effects. ⁽⁸⁾ Its primary research applications center on telomere biology, cellular aging (also spelled aging), and melatonin/circadian regulation. Pinealon (Glu-Asp-Arg, EDR tripeptide) was isolated from brain cortex tissue (Cortexin) and targets neurons and the central nervous system tissue broadly. ^(1,2) Its primary research applications center on neuroprotection, cognitive function, serotonin modulation, and neuronal survival under stress conditions.

The two peptides are complementary rather than competitive. Epithalon works at the cellular aging and telomere level while supporting melatonin production. Pinealon works at the gene expression and neuroprotection level while supporting serotonin synthesis and neuronal viability. Researchers investigating both pineal function and broader neuroprotection often use both compounds in their protocols. Healius offers both Epithalon (10mg and 50mg vials) and Pinealon (20mg vials).

1. Khavinson V, Linkova N, Kozhevnikova E, Trofimova S. EDR Peptide: Possible Mechanism of Gene Expression and Protein Synthesis Regulation Involved in the Pathogenesis of Alzheimer’s Disease. Molecules. 2021;26(1):159. PMC7795577. AD pathogenesis, serotonin/TPH1, caspase-3/p53, GPX1, SOD-2, PPARA/PPARG, dendritic spine preservation.

2. BiotechPeptides. Pinealon Peptide: Implications for Neuroprotection, Cellular Aging Mechanisms. 2024. Comprehensive review: Cortexin derivation, DNA interaction, nuclear penetration, circadian rhythm, cell viability, free radical suppression.

3. Wikipedia. Pinealon. Glu-Asp-Arg tripeptide. Prenatal hyperhomocysteinemia protection, learning retention in diabetic rats, and neuroprotective properties.

4. Fedoreyeva LI, Kireev II, Khavinson VKh, Vanyushin BF. Penetration of short fluorescence-labeled peptides into the nucleus in HeLa cells and in vitro specific interaction of the peptides with deoxyribooligonucleotides and DNA. Biochemistry (Mosc). 2011;76(11):1210-9. PMID: 22117547.

5. PeptideDeck. Pinealon (EDR Tripeptide) Complete Research Guide. 2026. Khavinson Institute history, organ-specific bioregulator mechanism, human trial (Kryzhanovskaya 2014, 60 adults 45-65), truck driver circadian study (Bashkireva 2012).

6. WADA Prohibited List 2026. Pinealon is not explicitly listed. S0 (Non-Approved Substances) catch-all may apply.

7. FDA Category 2 Bulk Drug Substances. September 2023. Pinealon is not listed.

8. Epithalon (AEDG tetrapeptide): Khavinson bioregulator targeting pineal gland telomerase activation and melatonin production. Complementary to Pinealon’s neuroprotective/serotonin mechanism.

This product is sold strictly for laboratory and research use only. It is not intended for human or animal consumption. It is not a dietary supplement, food, drug, or cosmetic. It is not intended to diagnose, treat, cure, or prevent any disease or condition. The buyer assumes all responsibility for the lawful use of this product in accordance with all applicable local, state, national, and international laws and regulations. By purchasing this product, the buyer confirms that they are a qualified researcher or are purchasing on behalf of a research institution.